Erythropoietin and prematurity – where do we stand?

References

1 Al-Kharfy T, JA Smyth, L Wadsworth, G Krystal, C Fitzgerald, J Davis, R Milner: Erythropoietin therapy in neonates at risk of having bronchopulmonary dysplasia and requiring multiple transfusions. J Pediatr129 (1996) 89Suche in Google Scholar

2 Anderson S, J Fangman, G Wager, D Uden: Retrieval of placental blood from the umbilical vein to determine volume, sterility and presence of clot formation. Am J Dis Child146 (1992) 36Suche in Google Scholar

3 Asch J, JF Wedgwood: Optimizing the approach to anemia in the preterm infant: is there a role for erythropoietin therapy? J Perinatol17 (1997) 276Suche in Google Scholar

4 Ballin A, A Bilker-Reich, E Arbel, Y Davidovitz, D Kohelet: Erythropoietin, given enterally, stimulates erythropoiesis in premature infants. Lancet353 (1999) 1849Suche in Google Scholar

5 Bard H, JA Widness: Effect of recombinant human erythropoietin on the switchover from fetal to adult hemoglobin synthesis in preterm infants. J Pediatr127 (1995) 478Suche in Google Scholar

6 Bechensteen AG, P Haga, S Halvorsen, A Whitelaw, K Liestol, R Lindemann, et al.: Erythropoietin, protein, and iron supplementation and the prevention of anemia of prematurity. Arch Dis Child Fetal Neonatal Ed69 (1993) 19Suche in Google Scholar

7 Bechensteen AG, P Haga, S Halvorsen, K Liestol, R Lindemann, A Whitelaw, et al.: Effect of low and moderate doses of recombinant human erythropoietin on the haematological response in premature infants on a high protein and iron intake. Eur J Pediatr156 (1997) 56Suche in Google Scholar

8 Bifano EM, TR Curran: Minimizing donor blood exposure in the neonatal intensive care unit: current trends and future prospects. Clin Perinatol22 (1995) 657Suche in Google Scholar

9 Brown MS, H Shapiro: Effect of protein intake on erythropoiesis during erythropoietin treatment of anemia of prematurity. J Pediatr128 (1996) 512Suche in Google Scholar

10 Carbonell X, J Figueras Aloy, JM Perez Fernández, A Fernández López, G Gonzalez Luis, MD Salvia Roiges: Usefulness of erythropoietin in the treatment of anemia of prematurity. Influence of birth weight. [Article in Spanish]. An Esp Pediatr51 (1999) 281Suche in Google Scholar

11 Carbonell Estrany X, J Figueras Aloy: Anaemia of prematurity: treatment with erythropoietin. Early Hum Dev65 (2001) S6210.1016/S0378-3782(01)00207-9Suche in Google Scholar

12 Casadevall Estrany N, J Nataf, B Viron, A Kolta, JJ Kiladjian, P Martin-Dupont, et al.: Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. N Engl J Med346 (2002) 469Suche in Google Scholar

13 De la Torre Aguilar MJ, FJ Gascón Jiménez, M Zapatero Martínez, J Guzmán Cabanas, D Huertas Muñoz, D Ruiz González, et al.: Prophylaxis of anemia of prematurity with erythropoietin. Case control study. [Article in Spanish]. An Esp Pediatr53 (2000) 243Suche in Google Scholar

14 Donato H, N Vain, P Rendo, N Vivas, L Prudent, M Larguia, et al.: Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: Results of a randomized, placebo-controlled, multicenter trial. Pediatrics105 (2000) 1066Suche in Google Scholar

15 Emmerson AJ, HJ Coles, CM Stern, TC Pearson: Double blind trial of recombinant human erythropoietin in preterm infants. Arch Dis Child68 (1993) 291Suche in Google Scholar

16 Emmerson AJB: Role of erythropoietin in the newborn. Arch Dis Child69 (1993) 27310.1136/adc.69.3_Spec_No.273Suche in Google Scholar

17 Eschbach JW, JC Egrie, MR Downing, JK Browne, JW Adamson: Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. N Engl J Med316 (1987) 73Suche in Google Scholar

18 Figueras Aloy J, X Carbonell Estrany: Blood extractions, transfusion policy and erythropoietin in the newborn. [Article in Spanish]. An Esp Pediatr49 (1998) 46Suche in Google Scholar

19 Franz AR, F Pohlandt: Red blood cel transfusions in very and extremely low birthweight infants under restrictive transfusion guidelines: is exogenous erythropoietin necessary? Arch Dis Child Fet Neonat Ed84 (2001) F9610.1136/fn.84.2.F96Suche in Google Scholar

20 Gallagher PG, RA Ehrenkranz: Erythropoietin therapy for anemia of prematurity. Clin Perinatol20 (1993) 169Suche in Google Scholar

21 Goodnough LT, TG Monk, GL Andriole: Erythropoietin therapy. N Engl J Med336 (1997) 933Suche in Google Scholar

22 Griffiths G, R Lall, S Chatfield, A Short, P Mackay, P Williamson, J Brown, MI Levene: Randomised controlled double blind study of role of recombinant erythropoietin in the prevention of chronic lung disease. Arch Dis Child Fetal Neonatal Ed76 (1997) F19010.1136/fn.76.3.F190Suche in Google Scholar

23 Guyton AC: Tratado de Fisiología Médica. Interamericana. MacGraw-Hill, Madrid 1992Suche in Google Scholar

24 Halperin DS, M Felix, P Wacker, G Lacourt, JF Babel, M Wyss: Recombinant human erythropoietin in the treatment of infants with anemia of prematurity. Eur J Pediatr151 (1992) 661Suche in Google Scholar

25 Halperin DS, P Wacker, G Lacourt, M Felix, JF Babel, M Aapro, M Wyss: Effects of recombinant human erythropoietin in infants with the anemia of prematurity: a pilot study. J Pediatr116 (1990) 779Suche in Google Scholar

26 Javier Manchon G, A Natal Pujol, W Coroleu Lletget, A Zuasnabar Cotro, J Badía Barnusell, J Junca Piera, et al.: Randomized multi-center trial of the administration of erythropoietin in anemia of prematurity. [Article in Spanish]. An Esp Pediatr46 (1997) 587Suche in Google Scholar

27 Juul S: Erythropoietin in the central nervous system, and its use to prevent hypoxic-ischemic brain damage. Acta Paediatr91(Suppl) (2002) 3610.1111/j.1651-2227.2002.tb02904.xSuche in Google Scholar

28 Juul S: Recombinant erythropoietin as a neuroprotective treatment: in vitro and in vivo models. Clin Perinatol31 (2004) 12910.1016/j.clp.2004.03.004Suche in Google Scholar

29 Juul SE, AE Joyce, Y Zhao, DJ Ledbetter: Why is erythropoietin present in human milk? Studies of erythropoietin receptors on enterocytes of human and rat neonates. Pediatr Res46 (1999) 263Suche in Google Scholar

30 Juul SE, Y Zhao, JB Dame, Y Du, AD Hutson, RD Christensen: Origin and fate of erythropoietin in human milk. Pediatr Res48 (2000) 660Suche in Google Scholar

31 Juul SE: Enterally dosed recombinant human erythropoietin does not stimulate erythropoiesis in neonates. J Pediatr143 (2003) 32110.1067/S0022-3476(03)00296-8Suche in Google Scholar

32 Juul SE: Nonerythropoietic roles of erythropoietin in the fetus and neonate. Clin Perinatol27 (2000) 52710.1016/S0095-5108(05)70037-3Suche in Google Scholar

33 Kling PJ, RL Schmidt, RA Roberts, JA Widness: Serum erythopoietin levels during infancy: association with erythropoiesis. J Pediatr128 (1996) 791Suche in Google Scholar

34 Kotto-Kome AC, MG Garcia, DA Calhoun, RD Christensen: Effect of beginning recombinant erythropoietin treatment within the first week of life, among very-low-birth-weight neonates, on “early” and “late” erythrocyte transfusions: a meta-analysis. J Perinatol24 (2004) 24Suche in Google Scholar

35 Kumral A, S Gonenc, O Acikgoz, A Sonmez, K Genc, O Yilmaz, et al.: Erythropoietin increases glutathione peroxidase enzyme activity and decreases lipid peroxidation levels in hipoxic-ischemic brain injury in neonatal rats. Biol Neonate87 (2005) 15Suche in Google Scholar

36 Lachance C, P Chessex, JC Fouron, JA Widness, H Bard: Myocardial, erythropoietic, and metabolic adaptations to anemia of prematurity. J Pediatr125 (1994) 278Suche in Google Scholar

37 Ledbetter DJ, SE Juul: Erythropoietin and the incidence of necrotizing enterocolitis in infants with very low birth weight. J Pediatr Surg35 (2000) 178Suche in Google Scholar

38 Maier RF, M Obladen, E Kattner, J Natzschka, J Messer, BM Regazzoni, et al.: High-versus low-dose erythropoietin in extremely low birth weight infants. The European Multicenter rhEPO Study Group. J Pediatr132 (1998) 866Suche in Google Scholar

39 Maier RF, M Obladen, I Muller-Hansen, E Kattner, U Merz, R Arlettaz, et al.: Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g. J Pediatr141 (2002) 8Suche in Google Scholar

40 Maier RF, M Obladen, P Scigalla, O Linderkamp, G Duc, G Hieronimi, et al.: The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group. N Engl J Med330 (1994) 1173Suche in Google Scholar

41 Meister B, A Khoss, G Burda, W Bock, M Kolmer, A Lischka, et al.: Decreasing reticulocyte counts associated with declining post-dose erythropoietin plasma levels in anaemia of prematurity. Biol Neonate74 (1998) 409Suche in Google Scholar

42 Messer J, J Haddad, L Donato, D Astruc, J Matis J: Early treatment of premature infants with recombinant human erythropoietin. Pediatrics92 (1993) 519Suche in Google Scholar

43 Meyer MP, C Haworth, JH Meyer, A Commerford: A comparison of oral and intravenous iron supplementation in preterm infants receiving recombinant erythropoietin. J Pediatr129 (1996) 258Suche in Google Scholar

44 Meyer MP, E Sharma, M Carsons: Recombinant erythropoietin and blood transfusion in selected preterm infants. Arch Dis Child Fet Neonat Ed88 (2003) F4110.1136/fn.88.1.F41Suche in Google Scholar PubMed PubMed Central

45 Meyer MP, JH Meyer, A Commerford, FM Hann, AA Sive, G Moller, J Jacobs, AF Malan: Recombinant human erythropoietin in the treatment of anemia of prematurity: results of a double blind, placebo-controlled study. Pediatrics93 (1994) 918Suche in Google Scholar

46 Obladen M, M Sachsenweger, M Stahnke: Blood sampling in very low birth weight infants receiving different levels of intensive care. Eur J Pediatr147 (1988) 399Suche in Google Scholar

47 Ohls RK, A Dai: Long-acting erythropoietin: clinical studies and potential uses in neonates. Clin Perinatol31 (2004) 77Suche in Google Scholar

48 Ohls RK, J Harcum, KR Schibler, RD Christensen: The effect of erythropoietin on the transfusion requirements of preterm infants weighing 750 grams or less: a randomized, double-blind, placebo-controlled study. J Pediatr131 (1997) 661Suche in Google Scholar

49 Ohls RK, KW Liechty, MC Turner, R Kimura, RD Christensen: Erythroid “burst promoting” activity in serum of patients with the anemia of prematurity. J Pediatr116 (1990) 786Suche in Google Scholar

50 Ohls RK, MW Veerman, RD Christensen: Pharmacokinetics and effectiveness of recombinant erythropoietin administered to preterm infants by continuous infusion in total parenteral nutrition. J Pediatr128 (1996) 518Suche in Google Scholar

51 Ohls RK, RA Ehrenkranz, A Das, AM Dusick, K Yolton K, E Romano, et al.: Neurodevelopmental outcome and growth at 18 to 22 months' corrected age in extremely low birth weight infants treated with early erythropoietin and iron. Pediatrics114 (2004) 1287Suche in Google Scholar

52 Ohls RK, RA Ehrenkranz, LL Wright, JA Lemons, SB Korones, BK Stoll, et al: Effects of early erythropoietin therapy on the transfusion requirements of preterm infants below 1250 grams birth weight: A multicenter, randomized, controlled trial. Pediatrics108 (2001) 934Suche in Google Scholar

53 Ohls RK, RD Christensen: Recombinant erythopoietin compared with erythrocyte transfusion in the treatment of anemia of prematurity. J Pediatr119 (1991) 781Suche in Google Scholar

54 Ohls RK: Erythropoietin treatment in extremely low birth weight infants: blood in versus blood out. J Pediatr141 (2002) 310.1067/mpd.2002.125853Suche in Google Scholar PubMed

55 Oski FA, JL Naiman: Hematologic problems in the newborn. 3rd edition. Saunders, Philadelphia 1982Suche in Google Scholar

56 Perapoch Lopez J, J Castilla Crespi, T Llopart Moragas, D Castella Cahiz, S Salcedo Abizanda: Reduction of exposure to multiple donors in premature newborns weighing less than 1,500 g at birth. [Article in Spanish]. An Esp Pediatr47 (1997) 551Suche in Google Scholar

57 Pollak A, M Hayde, M Hayn, K Herkner, KA Lombard, G Lubec, et al.: Effect of intravenous iron supplementation on erythropoiesis-treated premature infants. Pediatrics107 (2001) 78Suche in Google Scholar

58 Rigourd V, F Kieffer, MA Dommergues, A Ayachi, Z Assaf, I Mohamed, M Voyer, JF Magny: Érythopoïetine chez le nouveau-né: efficacité comparée des vois d'administration sous-cutanée et intraveineuse. Archiv Pediatr11 (2004) 319Suche in Google Scholar

59 Ringer SA, DK Richardson, RA Sacher, M Keszler, WH Churchill: Variations in transfusion practice in neonatal intensive care unit. Pediatrics101 (1998) 194Suche in Google Scholar

60 Rodriguez-Miguelez JM: Transfusiones en el recién nacido. Arch Pediatr (Barc)44 (1993) 90Suche in Google Scholar

61 Sastre Huerta E, B Alonso Alvarez, R Montero Alonso, T Alvarez Martín, F Barbadillo Izquierdo, I Carpintero Martín, et al.: Erythropoietin in anemia of the premature infant. Neonatal factors that are predictors of transfusión. [Article in Spanish]. An Esp Pediatr49 (1998) 49Suche in Google Scholar

62 Schaffer AJ, ME Avery: Disease of newborn. 6th edition, Saunders, Philadelphia 1991Suche in Google Scholar

63 Shannon K: Recombinant human erythropoietin in neonatal anemia. Clin Perinatol22 (1995) 62710.1016/S0095-5108(18)30272-0Suche in Google Scholar

64 Shannon KM, JF Keith 3rd, WC Mentzer, RA Ehrenkranz, MS Brown, JA Widness, et al.: Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants. Pediatrics95 (1995) 1Suche in Google Scholar

65 Shannon KM, WC Mentzer, RI Abels, P Freeman, N Newton, D Thompson, S Sniderman, R Ballard, RH Phibbs: Recombinant human erythropoietin in the anemia of prematurity: Results of a placebo-controlled pilot study. J Pediatr118 (1991) 949Suche in Google Scholar

66 Soubasi V, G Kremenopoulos, E Diamandi, C Tsantali, D Tsakiris: In which neonates does early recombinant human erythropoietin treatment prevent anemia of prematurity? Results of a randomized, controlled study. Pediatr Res34 (1993) 675Suche in Google Scholar

67 Soubasi V, G Kremenopoulos, E Diamanti, C Tsantali, K Sarafidis, D Tsakiris: Follow-up of very low birth weight infants after erythropoietin treatment to prevent anemia of prematurity. J Pediatr127 (1995) 291Suche in Google Scholar

68 Strauss RG.: Autologous transfusions for neonates using placental blood. A cautionary note. Am J Dis Child146 (1992) 2110.1001/archpedi.1992.02160130023013Suche in Google Scholar

69 Strauss RG: Recombinant erythropoietin for the anemia of prematurity: still a promise, not a panacea. J Pediatr131 (1997) 653Suche in Google Scholar

70 Strauss RG: Red blood cell transfusion practices in the neonate. Clin Perinatol22 (1995) 64110.1016/S0095-5108(18)30273-2Suche in Google Scholar

71 Vamvakas EC, RG Strauss: Meta-analysis of controlled clinical trials studying the efficacy of rHuEPO in reducing blood transfusions in the anemia of prematurity. Transfusion41 (2001) 406Suche in Google Scholar

72 Voyer M, JF Magny: Prématurité. Monographie de l'Encyclopédia Médico-Chirurgicale. Elsevier, Paris 1998Suche in Google Scholar

73 Widness JA, KA Lombard, EE Ziegler, RE Serfass, SJ Carlson, KJ Johnson, et al.: Erythrocyte incorporation and absorption of 58Fe in premature infants treated with erythropoietin. Pediatr Res41 (1997) 416Suche in Google Scholar

74 Wilimas JA, WM Crist: Erythopoietin – not yet a standard treatment for anemia of prematurity. Pediatrics95(1995) 910.1542/peds.95.1.9Suche in Google Scholar

75 Williamson P, G Griffiths, D Norfolk, M Levene: Blood transfusions and human recombinat erythopoietin in premature newborn infants. Arc Dis Child Fetal Neonatal Ed75 (1996) F6510.1136/fn.75.1.F65Suche in Google Scholar PubMed PubMed Central

76 Zaffanello M, M Franchini, S Rugolotto: Recombinant human erythropoietin might induce strawberry haemangiomas in very-low-birthweight preterm infants. Acta Paediatr92 (2003) 1353Suche in Google Scholar

77 Zipursky A: Erythropoietin therapy for premature infants: cost without benefit? Pediatr Res48 (2000) 13610.1203/00006450-200008000-00002Suche in Google Scholar PubMed